UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

BMC medicine, 2018-07, Vol.16 (1), p.104-104, Article 104

2018

Volltextzugriff (PDF)

Extranodal site of diffuse large B‐cell lymphoma and the risk of R‐CHOP chemotherapy resistance and early relapse

International journal of clinical practice (Esher), 2020-10, Vol.74 (10), p.e13594-n/a

2020

Volltextzugriff (PDF)

Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study

Health and quality of life outcomes, 2020-10, Vol.18 (1), p.347-347, Article 347

2020

Volltextzugriff (PDF)

Downregulation of hsa‐miR‐548d‐3p and overexpression of HOXA9 in diffuse large B‐cell lymphoma patients and the risk of R‐CHOP chemotherapy resistance and disease progression

International journal of laboratory hematology, 2022-10, Vol.44 (5), p.907-917

2022

Volltextzugriff (PDF)

Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study

Patient preference and adherence, 2019-08, Vol.13, p.1363-1373

2019

Volltextzugriff (PDF)

Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson’s disease in patients of Malay ancestry

Neurological sciences, 2021-10, Vol.42 (10), p.4203-4207

2021

Volltextzugriff (PDF)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders

International journal of hematology, 2010-01, Vol.91 (1), p.136-139

2010

Volltextzugriff (PDF)

Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis

Critical reviews in oncology/hematology, 2019-12, Vol.144, p.102818-102818, Article 102818

2019

Volltextzugriff (PDF)

Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

Supportive care in cancer, 2020-07, Vol.28 (7), p.3237-3247

2020

Volltextzugriff (PDF)

Lipocalin‐2 is associated with modulation of disease phenotype in a patient with concurrent JAK2‐V617F and BCR‐ABL mutation

European journal of haematology, 2012-02, Vol.88 (2), p.175-178

2012

Volltextzugriff (PDF)

Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population

Journal of human genetics, 2014-05, Vol.59 (5), p.280-287

2014

Volltextzugriff (PDF)

Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate

International journal of hematology, 2011-04, Vol.93 (4), p.465-473

2011

Volltextzugriff (PDF)

Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies

Pharmacogenomics, 2014-08, Vol.15 (11), p.1479-1494

2014

Volltextzugriff (PDF)

Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

Supportive care in cancer, 2020-07, Vol.28 (7), p.3249-3249

2020

Volltextzugriff (PDF)

Expert consensus on the management of chronic lymphocytic leukaemia in Asia

Clinical and experimental medicine, 2023-10, Vol.23 (6), p.2895-2907

2023

Volltextzugriff (PDF)

Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review

Patient preference and adherence, 2021-01, Vol.15, p.2563-2575

2021

Volltextzugriff (PDF)

Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia

Journal of oncology pharmacy practice, 2021-10, Vol.27 (7), p.1644-1656

2021

Volltextzugriff (PDF)

Luspatercept‐induced reduction in transfusion requirement in α‐thalassemia

EJHaem, 2020-07, Vol.1 (1), p.297-299

2020

Volltextzugriff (PDF)

CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country

Indian journal of hematology & blood transfusion, 2024, Vol.40 (1), p.97-102

2024

Volltextzugriff (PDF)

Identification of protein markers in patients infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax

International journal of molecular sciences, 2014-11, Vol.15 (11), p.19952-19961

2014

Volltextzugriff (PDF)

SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression

Scientific reports, 2017-01, Vol.7 (1), p.41400-41400, Article 41400

2017

Volltextzugriff (PDF)

A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy

Journal Of Movement Disorders, 2018, 11(2), , pp.89-92

2018

Volltextzugriff (PDF)

Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population

Leukemia & lymphoma, 2015-01, Vol.56 (1), p.163-168

2015

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(73)
Berichte
(4)

Sprache

Englisch
(74)
Koreanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

Extranodal site of diffuse large B‐cell lymphoma and the risk of R‐CHOP chemotherapy resistance and early relapse

Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study

Downregulation of hsa‐miR‐548d‐3p and overexpression of HOXA9 in diffuse large B‐cell lymphoma patients and the risk of R‐CHOP chemotherapy resistance and disease progression

Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study

Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson’s disease in patients of Malay ancestry

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders

Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis

Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

Lipocalin‐2 is associated with modulation of disease phenotype in a patient with concurrent JAK2‐V617F and BCR‐ABL mutation

Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population

Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate

Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies

Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia

Expert consensus on the management of chronic lymphocytic leukaemia in Asia

Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review

Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia

Luspatercept‐induced reduction in transfusion requirement in α‐thalassemia

CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country

Identification of protein markers in patients infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax

SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression

A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy

Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population

Suchergebnisse filtern